Midostaurin in Advanced Systemic Mastocytosis: A Systematic Review and Meta-analysis

Am J Ther. 2023 Nov-Dec;30(6):e573-e575. doi: 10.1097/MJT.0000000000001508. Epub 2022 Apr 21.

Authors

Ziad Abuhelwa¹, Azizullah Beran¹, Navkirat Kahlon², Wasef Sayeh¹, Waleed Khokher¹, Ragheb Assaly^{1

3}, Danae M Hamouda²

Affiliations

¹ Department of Internal Medicine, University of Toledo, Toledo, OH.
² Division of Hematology and Oncology, Department of Internal Medicine, University of Toledo, Toledo, OH.
³ Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, University of Toledo, Toledo, OH.

PMID: 35446286
DOI: 10.1097/MJT.0000000000001508

No abstract available

Publication types

Meta-Analysis
Systematic Review
Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Humans
Mastocytosis, Systemic* / drug therapy
Staurosporine / therapeutic use

Substances

midostaurin
Staurosporine
Antineoplastic Agents